Drugs / Multiple low dose cyclophosphamide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01094548 | Jan 2008 → Feb 2011 | plasma cell myeloma | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Multiple low dose cyclophosphamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01094548 ↗ |
| Route | Intravenous | “An IV infusion of 300 mg/m\^2” NCT01094548 ↗ |